Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
ACTIFLIP, baseline, bioabsorbable, Biocomposite, carbon, certification, CIS, Climate, CSF, delegated, earlier, EEA, emitter, expiry, Fischetti, footprint, freight, Gary, gas, GHG, GLENOJET, greenhouse, incident, inflationary, injured, instruction, Internet, intranet, lab, lawfully, layered, modular, module, monthly, neutrality, NIST, onboarding, OVO, patch, PEEK, PF, Polyetheretherketone, proportion, proven, role, scaffold, SPEEDSPIRAL, tendon, TIGHT, tradename, true, UKNI, vCISO, version, vigilance, virtual, VP, warming, WAVE, WAVEKAHUNA
Removed:
accessibility, accrual, aforementioned, alternate, altogether, applying, arrive, assumed, avoided, back, Button, calculate, cancellation, Carlo, caution, consisted, Darling, death, decided, drawdown, duration, eliminating, ending, enroll, epidemic, essential, evolutionary, exacerbate, executed, expectation, factually, forfeited, forma, formed, hyalobone, hyalonect, impair, Italian, Joseph, lapse, launch, light, materialize, Monte, occurred, phishing, precautionary, principle, pro, purport, ranged, recapture, reconstruction, recreate, recruiting, refinement, reliance, remote, renewed, repaid, Representative, scenario, serving, sick, simulated, simulation, specialist, spread, sum, supervision, supplemental, transit, transport, transportation, TSR, unaudited, unexpectedly, WIP, Wisconsin, yearly
Filing tables
Filing exhibits
Related press release
Associated ANIK transcripts
ANIK similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-219190, 333-232254, 333-239304, 333-258529, 333-258530, 333-260821, 333-266550, 333-273812, and 333-276622 on Form S-8 of our reports dated March 15, 2024, relating to the financial statements of Anika Therapeutics, Inc. (the “Company”), and the effectiveness of the Company’s internal control over financial reporting, appearing in this Annual Report on Form 10-K of Anika Therapeutics, Inc. for the year ended December 31, 2023.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
March 15, 2024